Canadian Urological Association / L'Association des urologues du Canada

Canadian Urological Association (CUA)

Health EN ↓ Odcinki: 102

The official podcast of the Canadian Urological Association (CUA).Le podcast officiel de l'association des urologues du Canada (AUC).

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: cua.simplecast.com

Autor

Canadian Urological Association / L'Association des urologues du Canada

Kategoria

Health

Strona podcastu

cua.simplecast.com

Ostatni odcinek

4 mar 2025

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

CUA Highlights of ASCO 2021 - Bladder Cancer session - French 09.06.2021 59:45

Disclosures: Fabio Cury Educational grants: Sanofi S.A., Boston Scientific Honoraria/Travel Support: Varian Medical Systems, Bayer AG, Abbvie Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayey Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership position: Point Biopharma Di (Maria) Jiang Speaker's honoraria: Ipsen,...

CUA Highlights of ASCO 2021 - Prostate Cancer Session 09.06.2021 59:07

Disclosures: Brita Danielson Honoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, Janssen Nazanin Fallah-Rad Consultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeutics Honorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, Merck Travel Grants: Nekktar Therapeutics Vincent Fradet Consultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen,...

CUA Highlights of ASCO 2021 - Bladder Cancer session 09.06.2021 59:45

CUA Highlights of ASCO 2021 - Kidney Cancer Session 09.06.2021 52:26

Disclosures: Daniel Heng Consultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, Ipsen Anand Swaminath Advisory board: Astrazeneca Expert Speaker: Astrazeneca, BMS, Eisai Grants (in kind): BMS, Roche Rodney Breau No disclosures

CUA Highlights of ASCO 2021 - Kidney Cancer Session - French 09.06.2021 52:35

CUA Highlights of ASCO 2021 - Prostate Cancer Session - French 09.06.2021 59:18

CUA Practice Changing Publications (PCP) in Pediatric Urology 06.05.2021 1:01:49

Disclosures: No disclosures

CUA Practice Changing Publications (PCP): An Update in Men's Health 28.04.2021 53:06

Disclosures: Jeffrey Campbell Advisory Board/Grant/Honorarium: Boston Scientific, Abbvie, Paladin Labs Premal Patel Advisory Board/Grant/Honorarium: Boston Scientific

Practice Changing Publications (PCP): Management of MIBC 01.04.2021 1:00:26

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase Ross Mason Advisory Boards: Astellas, Abbvie, TerSara, Verity Grants/Honoraria: Abbvie, Sanofi, TerSara, Bladder Cancer Canada Clinical Trials: Merck, Bayer

Practice Changing Publications (PCP): Urolithiasis 01.03.2021 1:01:16

Disclosures: Andrea G. Lantz Powers none Ben Chew Consultant: Bard Medical, Boston Scientific, Cook Medical, Olympus, Poly-Med, Adva-TEC inc., Auris Surgical, Coloplast Speakers Bureau: Boston Scientific, Cook Medical, Olympus, Coloplast Grants: Boston Scientific, Cook Medical, Olympus Clinical Trials: Olympus, Bosotn Scientific, Cook Medical

Simplifying mCSPC: Improving Patient Management and Outcomes 24.02.2021 40:10

Disclosures: Ricardo Rendon Advisory Board: Astellas, Amgen, Abbvie, Janssen, Bayer, AstraZeneca, Ferring, Sanofi Speakers Bureau: Astellas, Amgen, Ferring, Janssen Clinical Trials: Amgen, Astellas, Abbvie, Ferring, Janssen, AstraZeneca, Sanofi, Pfizer, Myovant

Practice Changing Publications (PCP) in Functional Urology: A Year in Review 26.01.2021 1:00:43

Disclosures: Ashley Cox Advisory Board: Astellas, Pfizer, Teva Clinical Trial: Aquinox Laura Nguyen Speakers Bureau: Astella, Pfizer Grant/Honorarium: Ontario College of Family Physicians

Launching the CUA Podcast! 01.01.2021 0:36

The Canadian Urological Association is excited to be launching its new podcast series! Subscribe today to make sure you stay up to date with the latest episodes from CUA – The voice of urology in Canada. Visit cua.org for more info!

CUA Q & A Series | Topic: Evolution of Landscape 05.12.2020 46:42

Evolution of Landscape (Q&A Series) 0:00 - Neil Fleshner 3:30 - Martin Gleave 11:20 - Mira Keyes 15:40 - Laurence Klotz 20:34 - Abdenour Nabid 26:25 - Tamim Niazi 33:35 - Fred Saad 38:35 - Bobby Shayegan

CUA Q & A Series | Topic: Intermittent vs Continuous 05.12.2020 56:56

Intermittent vs Continuous (Q&A Series) 0:00 - Neil Fleshner 2:50 - Martin Gleave 10:30 - Mira Keyes 17:30 - Laurence Klotz 24:30 - Abdenour Nabid 29:35 - Tamim Niazi 35:05 - Fred Saad 40:50 - Bobby Shayegan

CUA Q & A Series | Topic: Androgen Deprivation Therapy 05.12.2020 22:28

Androgen Deprivation Therapy (Q&A series) 0:00 - Mira Keyes 9:53 - Abdenour Nabid 14:55 - Tamim Niazi

CUA Q & A Series | Topic: Early vs Delayed Therapy 05.12.2020 59:41

Early vs Delayed Therapy (Q&A Series) 0:00 - Neil Fleshner 3:27 - Martin Gleave 11:52 - Mira Keyes 21:10 - Laurence Klotz 28:40 - Abdenour Nabid 37:10 - Tamim Niazi 44:05 - Fred Saad 49:55 - Bobby Shayegan

Laurence Klotz | Low T & Breakthrough | Q&A Series 05.12.2020 3:59

Low T & Breakthrough - Laurence Klotz

Neil Fleshner | Low T & Breakthrough | Q&A Series 05.12.2020 1:26

Low T & Breakthrough - Neil Fleshner

Abdenour Nabid | ADT Duration with Radiation | Q&A Series 05.12.2020 5:16

ADT Duration with Radiation - Abdenour Nabid

Tamim Niazi | ADT Duration with Radiation | Q&A Series 05.12.2020 8:04

ADT Duration with Radiation - Tamim Niazi

Bobby Shayegan | Low T & Breakthrough | CUA Q&A Series 05.12.2020 7:44

Martin Gleave | Early vs Delayed Therapy | Q&A Series 05.12.2020 9:00

Early vs Delayed Therapy - Martin Gleave

Laurence Klotz | Early vs Delayed Therapy | Q&A Series 05.12.2020 8:00